Filgrastim following HLA-Identical Allogeneic Bone Marrow Transplantation: Long-Term Outcomes of a Randomized Trial

This publication has 18 references indexed in Scilit:

• Growth factor‐associated graft‐versus‐host disease and mortality 10 years after allogeneic bone marrow transplantation
  British Journal of Haematology, 2012
• A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation
  Archives of Drug Information, 2008
• Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation
  Journal of Clinical Oncology, 2006
• Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation
  Blood, 2006
• Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation
  Leukemia, 2005
• Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
  Journal of Clinical Oncology, 2004
• The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis
  Bone Marrow Transplantation, 2003
• G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II–IV
  Bone Marrow Transplantation, 2003
• Transplantation of peripheral blood progenitor cells from HLA‐identical sibling donors
  British Journal of Haematology, 1996
• VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION
  Transplantation, 1987